{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:10:53Z","timestamp":1760170253702,"version":"3.44.0"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2000,10,1]],"date-time":"2000-10-01T00:00:00Z","timestamp":970358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2000,10,1]],"date-time":"2000-10-01T00:00:00Z","timestamp":970358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"vor","delay-in-days":2191,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2000,10]]},"DOI":"10.1016\/s0037-1963(00)90064-7","type":"journal-article","created":{"date-parts":[[2005,11,3]],"date-time":"2005-11-03T07:48:22Z","timestamp":1131004102000},"page":"18-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"S6","title":["Anemia and human immunodeficiency virus disease in the era of highly active antiretroviral therapy"],"prefix":"10.1016","volume":"37","author":[{"given":"Richard D","family":"Moore","sequence":"first","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0037-1963(00)90064-7_BIB1","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1086\/520178","article-title":"Human immunodeficiency virus infection, anemia, and survival","volume":"29","author":"Moore","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S0037-1963(00)90064-7_BIB2","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1097\/00002030-199910010-00017","article-title":"Natural history of HIV infection in the era of combination antiretroviral therapy","volume":"13","author":"Moore","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/S0037-1963(00)90064-7_BIB3","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/S0037-1963(00)90064-7_BIB4","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1001\/jama.282.23.2220","article-title":"AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy","volume":"282","author":"Lederberger","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/S0037-1963(00)90064-7_BIB5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/blood.V91.1.301","article-title":"Epidemiology of anemia in human immunodeficiency virus (HIV)-infected persons: Results from the multistate adult and adolescent spectrum of HIV disease surveillance project","volume":"91","author":"Sullivan","year":"1998","journal-title":"Blood"},{"key":"10.1016\/S0037-1963(00)90064-7_BIB6","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/00002030-199905280-00010","article-title":"Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe","volume":"13","author":"Mocroft","year":"1999","journal-title":"AIDS"},{"issue":"suppl 1","key":"10.1016\/S0037-1963(00)90064-7_BIB7","first-page":"8b","article-title":"Anemia in HIV disease in the HAART era: Is it common?","volume":"94","author":"Sharp","year":"1999","journal-title":"Blood"},{"key":"10.1016\/S0037-1963(00)90064-7_BIB8","series-title":"Presented at the 6th Conference on Retroviruses and Opportunistic Infections","article-title":"Improved survival with correction of anemia in HIV disease","author":"Moore","year":"1999"},{"key":"10.1016\/S0037-1963(00)90064-7_BIB9","first-page":"474","article-title":"Recombinant human erythropoietin and health-related quality of life of AIDS patients with anemia","volume":"7","author":"Revicki","year":"1994","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"suppl 1","key":"10.1016\/S0037-1963(00)90064-7_BIB10","first-page":"10b","article-title":"Epoetin alfa improves the quality of life (QOL) in HIV+ patients with anemia","volume":"92","author":"Abrams","year":"1998","journal-title":"Blood"},{"key":"10.1016\/S0037-1963(00)90064-7_BIB11","series-title":"Presented at the 37th Annual Meeting of the Infectious Diseases Society of America","article-title":"Once-weekly dosing of epoetin alfa increases hemoglobin and quality of life in HIV-positive patients with anemia","volume":"131","author":"Saag","year":"1999"},{"key":"10.1016\/S0037-1963(00)90064-7_BIB12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00042560-199809010-00004","article-title":"Anemia and survival in HIV infection","volume":"19","author":"Moore","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retroviral"},{"key":"10.1016\/S0037-1963(00)90064-7_BIB13","first-page":"1258","article-title":"CD4+ lymphocyte response to zidovudine as a predictor of AIDS-free time and survival time","volume":"6","author":"Graham","year":"1993","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/S0037-1963(00)90064-7_BIB14","series-title":"Presented at the 12th Annual HIV\/AIDS Update Conference","article-title":"A case-control study examining the association of disease prognosis with the development and treatment of anemia in patients infected with HIV","author":"Creagh","year":"2000"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196300900647?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196300900647?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:12:34Z","timestamp":1758521554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196300900647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,10]]},"references-count":14,"alternative-id":["S0037196300900647"],"URL":"https:\/\/doi.org\/10.1016\/s0037-1963(00)90064-7","relation":{},"ISSN":["0037-1963"],"issn-type":[{"type":"print","value":"0037-1963"}],"subject":[],"published":{"date-parts":[[2000,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anemia and human immunodeficiency virus disease in the era of highly active antiretroviral therapy","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0037-1963(00)90064-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2000 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}